The invention
Circulating Thrombospondin-2 (TSP2) - A novel fibrosis biomarker for patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
The invention
- Name of invention
- Circulating Thrombospondin-2 (TSP2) - A novel fibrosis biomarker for patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
- Thrombospondine-2 circulante (TSP2) - Un nouveau biomarqueur de fibrose pour les patients atteints de diabète de type 2 et de maladie hépatique stéatosique associée à un dysfonctionnement métabolique
Invention description
- Description
- Circulating thrombospondin-2 levels as a simple and non-invasive blood biomarker to predict the presence and development of advanced liver fibrosis, a crucial stage of steatotic liver disease impacting the progression.
INVENTORS
Aimin XU inventor 3727293077_3315
Karen Siu-Ling LAM inventor 3727293077_3314
Chi-Ho LEE inventor 3727293077_3313
The University of Hong Kong inventor 3727293077_3106
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.